Effects of Prednisolone, l-Asparaginase, Gemfibrozil, and Combinations of These Elements on Mice Lipid Profile, Liver, and Pancreas

Basit Öğe Kaydı
dc.contributor.authorKose, Dogan
dc.contributor.authorTarakci, Nuriye
dc.contributor.authorCelik, Zeliha Esin
dc.contributor.authorVatansev, Husamettin
dc.contributor.authorCimbek, Emine Ayca
dc.contributor.authorUgras, Serdar
dc.contributor.authorSen, Yasar
dc.date.accessioned2020-03-26T19:23:51Z
dc.date.available2020-03-26T19:23:51Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe aim of this study is to determine the effects of l-asparaginase (l-ASP), corticosteroids (CSs), and antilipidemics, separately and in combination, on the lipid profiles and the liver and pancreas histology in mice. This study included 8 groups of 7 mice each. Before any drug administration, serum samples were taken from all of the mice. Then, normal saline was applied to the control group, and a medication or combination of medications was applied to the other groups. Levels of triglycerides, cholesterol (COL), and high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were determined, and the livers and pancreases were evaluated histologically at the end of the study. Triglycerides increased significantly in the CS-only and the l-ASP-only groups, COL increased significantly in the CS-only group, and HDL increased significantly in the CS-only and the antilipidemic-only groups. LDL was significantly lower in the CS-only and the l-ASP-only groups. CSs and l-ASP were significantly effective in liver necrosis, l-ASP was significantly effective in liver balloon degeneration, and CS were significantly effective in pancreas vacuolization. Triglyceride measurement is recommended before/during CS and/or l-ASP treatment. Starting with an antilipidemic agent can be considered to avoid possible complications in patients with significantly high rates. Indicators of a possible liver or pancreas injury should also be considered.en_US
dc.description.sponsorshipSelcuk UniversitySelcuk Universityen_US
dc.description.sponsorshipSupported by Selcuk University.en_US
dc.identifier.doi10.1097/MPH.0000000000000484en_US
dc.identifier.endpageE49en_US
dc.identifier.issn1077-4114en_US
dc.identifier.issn1536-3678en_US
dc.identifier.issue1en_US
dc.identifier.pmid26599986en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageE42en_US
dc.identifier.urihttps://dx.doi.org/10.1097/MPH.0000000000000484
dc.identifier.urihttps://hdl.handle.net/20.500.12395/33514
dc.identifier.volume38en_US
dc.identifier.wosWOS:000372838700012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen_US
dc.relation.ispartofJOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectprednisoloneen_US
dc.subjectlipiden_US
dc.subjectasparaginaseen_US
dc.subjectgemfibrozilen_US
dc.titleEffects of Prednisolone, l-Asparaginase, Gemfibrozil, and Combinations of These Elements on Mice Lipid Profile, Liver, and Pancreasen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu